Vaccine Contract Manufacturing Market Dynamics and Opportunities 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Vaccine Contract Manufacturing Market covers analysis by Vaccine Type (Inactivated Vaccines, Attenuated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines); Workflow Type (Downstream, Upstream); Application (Human Use, Veterinary), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Sep 2025
  • Report Code : TIPRE00006980
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The Vaccine Contract Manufacturing Market is expected to register a CAGR of 11.3% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The Vaccine Contract Manufacturing Market report covers analysis by Vaccine Type (Inactivated Vaccines, Attenuated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines); Workflow Type (Downstream, Upstream); Application (Human Use, Veterinary), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.

Purpose of the Report

The report Vaccine Contract Manufacturing Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Vaccine Contract Manufacturing Market Segmentation

Vaccine Type

  • Inactivated Vaccines
  • Attenuated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines

Workflow Type

  • Downstream
  • Upstream

Application

  • Human Use
  • Veterinary

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Vaccine Contract Manufacturing Market: Strategic Insights

vaccine-contract-manufacturing-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Vaccine Contract Manufacturing Market Growth Drivers

  • Increasing Demand for Vaccines: The increasing rate of infectious diseases and the rapidly increasing incidence of pandemics have increased the demand for vaccines by a great margin. Governments and healthcare organizations are focusing on immunization programs to prevent outbreaks, which has caused a surge in vaccine production. Contract manufacturers have become an essential part of fulfilling this increased demand by offering scalable and efficient manufacturing solutions.
  • Outsourcing Trends in the Pharmaceutical Industry: Pharmaceutical companies are outsourcing vaccine production to CMOs for the reasons of cost saving, focusing on core competencies, and accelerating time-to-market. Outsourcing to CMOs allows the companies to utilize their expertise and sophisticated facilities, thus ensuring high-quality production without capital investment in manufacturing infrastructure.
  • Technological Improvements in Vaccine Manufacturing: There have been recent breakthroughs in biotechnology. mRNA vaccine technology, for example, and recombinant vaccine production. These developments lead to faster, more efficient production cycles, which are exactly what contract manufacturers are equipped to adopt and implement. Producing complex vaccines through the latest available technologies puts the CMO at the center of vaccine supply chain delivery.

Vaccine Contract Manufacturing Market Future Trends

  • Concentration on Vaccine Quality and Regulatory Compliance: Quality and safety of the vaccine are major factors, leading to stringent regulations. CMOs are now looking at good quality control systems as well as ensuring compliance with regulation, which enables these contract manufacturers to compete on an international scale by maintaining products based on universal quality parameters to ensure that these products do not harm their target consumer and ensure higher reputation as well as a market share.
  • Increased Collaboration and Partnerships: Collaborations between pharmaceutical companies, biotech firms, and CMOs are on the rise. Such collaborations allow for the sharing of resources, expertise, and technologies, which can lead to more efficient vaccine development and production processes. Such collaborations are essential for scaling up production rapidly and addressing global vaccine needs, especially during health crises.
  • Digital and Automation Technologies Adoption: Process digitalization and automation are revolutionizing processes in the manufacture of vaccines for efficient, precise, and scalable production. CMOs adopt technologies such as AI, ML, and robotics in operations to enhance productivity, minimize human error, and streamline operations. This supports the production of quality vaccines at a faster pace.

Vaccine Contract Manufacturing Market Opportunities

  • Public-Private Partnerships: Public-private partnerships give CMOs ample opportunities to partner with governments and overseas organizations in vaccine manufacturing. In a public-private partnership, the partner would often provide necessary financing, technical assistance, and a market for vaccines that guarantees the viability and success of the manufacturing project. This involvement can also improve the reputation and position of CMOs in the marketplace.
  • Increased scope for Vaccine portfolios: With an increasing requirement for a diverse set of vaccines that include infectious diseases and those for travel and travel-related disorders, CMOs can increase their market and thereby their growth prospects. More so, developing diverse portfolios with the help of vaccine development has enhanced the competencies of CMOs and paved their way toward greater revenue potential. This diversity involves research-based investment in the identification of new threats to health to manufacture vaccines accordingly.
  • Personalized Vaccines: Personalized vaccines, based on an individual's genetic makeup or other individual health conditions, are one of the bright areas for growth. CMOs could specialize in building up the necessary infrastructure and developing professional skills to manufacture personalized vaccines. The burgeoning desire for personalized healthcare solutions presents a significant market opportunity for contract manufacturers to innovate and differentiate their services.

Vaccine Contract Manufacturing Market Regional Insights

The regional trends and factors influencing the Vaccine Contract Manufacturing Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Vaccine Contract Manufacturing Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

vaccine-contract-manufacturing-market-global-geography
  • Get the Regional Specific Data for Vaccine Contract Manufacturing Market

Vaccine Contract Manufacturing Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 11.3%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Vaccine Type
  • Inactivated Vaccines
  • Attenuated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
By Workflow Type
  • Downstream
  • Upstream
By Application
  • Human Use
  • Veterinary
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Lonza
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • Merck KGaA
  • AbbVie Inc.
  • Cytovance Biologics
  • Catalent, Inc.
  • IDT Biologika
  • ICON plc.
  • Albany Molecular Research Inc. (AMRI)

  • Vaccine Contract Manufacturing Market Players Density: Understanding Its Impact on Business Dynamics

    The Vaccine Contract Manufacturing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Vaccine Contract Manufacturing Market are:

    1. Lonza
    2. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
    3. Merck KGaA
    4. AbbVie Inc.
    5. Cytovance Biologics
    6. Catalent, Inc.

    Disclaimer: The companies listed above are not ranked in any particular order.


    vaccine-contract-manufacturing-market-cagr

    • Get the Vaccine Contract Manufacturing Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Vaccine Contract Manufacturing Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Vaccine Contract Manufacturing Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    What are the major driving factors impacting the Vaccine Contract Manufacturing Market?

    The major factors driving the Vaccine Contract Manufacturing Market are Increasing Demand for Vaccines, Outsourcing Trends in the Pharmaceutical Industry, and Technological Improvements in Vaccine Manufacturing

    What are the future trends of the Vaccine Contract Manufacturing Market?

    The key future trends of the market are Concentration on Vaccine Quality and Regulatory Compliance, Increased Collaboration and Partnerships, and Digital and Automation Technologies Adoption

    Which are the leading players operating in the Vaccine Contract Manufacturing Market?

    The leading players operating in the Vaccine Contract Manufacturing Market include Lonza, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Merck KGaA, AbbVie Inc., Cytovance Biologics, Catalent, Inc., IDT Biologika, ICON plc., Albany Molecular Research Inc. (AMRI).

    What are the deliverable formats of Vaccine Contract Manufacturing Market report?

    The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

    What are the options available for the customization of this report?

    Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    1. Lonza
    2. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
    3. Merck KGaA
    4. AbbVie Inc.
    5. Cytovance Biologics
    6. Catalent, Inc.
    7. IDT Biologika
    8. ICON plc.
    9. Albany Molecular Research Inc. (AMRI)
    10. Charles River
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo